Millennials Getting More Obesity-Related Cancers, Study Finds
This study shows the incidence of cancer associated with obesity has been rising dramatically in groups of individuals born in more recent decades,” said MD Anderson Cancer Center’s Dr. George Chang, who was not associated with the analysis. However, Chang warns against overgeneralizing on the basis of an epidemiological study. “The study was not set up to establish causation,” Chang said. “We know there are many factors that are associated with both obesity and cancer, such as lack of exercise and poor diet. How much each of those factors contribute to cancer is less clear.” Obesity is ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 4, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer CNN Millennials Source Type: news

Some Cancers Are Rising in Young People. Scientists Think They Know Why
The rates of new cancer cases and cancer deaths have fallen in the U.S. over the past few decades. But certain cancers are becoming more common among younger Americans, and researchers think obesity may be to blame, finds a new report from the American Cancer Society and the National Cancer Institute. Rates of six different cancers that are associated with obesity increased among adults ages 25-49 between 1995 and 2014, according to the research, which was published in the journal Lancet Public Health and based on information in the Cancer in North America database. These cancers include multiple myeloma, colorectal, endom...
Source: TIME: Health - February 4, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Source Type: news

Some Cancers Are Rising in Millennials. Obesity Might Be the Reason Why
The rates of new cancer cases and cancer deaths have fallen in the U.S. over the past few decades. But certain cancers are becoming more common among younger Americans, and researchers think obesity may be to blame, finds a new report from the American Cancer Society and the National Cancer Institute. Obesity rates have been rising across age groups for years. According to the latest federal numbers, almost 36% of American adults ages 20-39 are obese, and that number may soon be even higher. Recent research suggests that if obesity trends continue, 57% of children in the U.S. will be obese by the time they turn 35. Rates ...
Source: TIME: Health - February 4, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Source Type: news

Some Cancers Are Rising in Millennials. Obesity Might Be Why
The rates of new cancer cases and cancer deaths have fallen in the U.S. over the past few decades. But certain cancers are becoming more common among younger Americans, and researchers think obesity may be to blame, finds a new report from the American Cancer Society and the National Cancer Institute. Obesity rates have been rising across age groups for years. According to the latest federal numbers, almost 36% of American adults ages 20-39 are obese, and that number may soon be even higher. Recent research suggests that if obesity trends continue, 57% of children in the U.S. will be obese by the time they turn 35. Rates ...
Source: TIME: Health - February 4, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Source Type: news

23andMe Has a New Genetic Cancer Test. But the Results Don ’t Tell You the Whole Story
Consumer genetics company 23andMe is diving deeper into the medical space. On Jan. 22, the company announced that the Food and Drug Administration (FDA) approved its newest report, which can flag whether people have genetic variants that may raise their risk of developing colorectal cancer. The new test looks for two gene variants associated with MUTYH-associated polyposis, an inherited colorectal cancer syndrome. “If left unchecked, carrying both of these variants or having two copies of one increases the risk of developing colorectal cancer to between 43 and 100 percent,” according to 23andMe. The test will b...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Source Type: news

World Cancer Day
is an international day marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment. 2019 marks the launch of the 3-year ‘I Am and I Will’ campaign; an empowering call-to-action urging for personal commitment and represents the power of individual action taken now to impact the future.Cochrane Cancer supports and coordinates the work acrossmultiple Cochrane Review Groups dealing with the topic of Cancer. These  Cochrane Review Groups provide reliable evidence required to make important decisions on issues concerning cancer and related topics. Cochrane R...
Source: Cochrane News and Events - January 14, 2019 Category: Information Technology Authors: Muriah Umoquit Source Type: news

More Data Tie Obesity to Occult Endometrial Cancer
(MedPage Today) -- Bariatric surgery appeared to normalize neoplastic endometrium in some women (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 1, 2018 Category: Endocrinology Source Type: news

New study takes first step toward treating endometriosis
(Northwestern University) Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 1, 2018 Category: Cancer & Oncology Source Type: news

COUNTERPOINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?
The routine use of adjuvant radiation therapy in stage III endometrial cancer patients is not supported by the current literature and should not be employed universally in this group of patients. (Source: CancerNetwork)
Source: CancerNetwork - September 19, 2018 Category: Cancer & Oncology Authors: John P. Diaz, MD, FACOG Source Type: news

POINT: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?
Adjuvant radiation therapy provides a local control benefit in stage III endometrial carcinoma patients, as strongly suggested in retrospective and prospective series. (Source: CancerNetwork)
Source: CancerNetwork - September 18, 2018 Category: Cancer & Oncology Authors: Mark E. Bernard, MD, Marcus E. Randall, MD Source Type: news

Minimal functional driver gene heterogeneity among untreated metastases
Metastases are responsible for the majority of cancer-related deaths. Although genomic heterogeneity within primary tumors is associated with relapse, heterogeneity among treatment-naïve metastases has not been comprehensively assessed. We analyzed sequencing data for 76 untreated metastases from 20 patients and inferred cancer phylogenies for breast, colorectal, endometrial, gastric, lung, melanoma, pancreatic, and prostate cancers. We found that within individual patients, a large majority of driver gene mutations are common to all metastases. Further analysis revealed that the driver gene mutations that were not share...
Source: ScienceNOW - September 6, 2018 Category: Science Authors: Reiter, J. G., Makohon-Moore, A. P., Gerold, J. M., Heyde, A., Attiyeh, M. A., Kohutek, Z. A., Tokheim, C. J., Brown, A., DeBlasio, R. M., Niyazov, J., Zucker, A., Karchin, R., Kinzler, K. W., Iacobuzio-Donahue, C. A., Vogelstein, B., Nowak, M. A. Tags: Medicine, Diseases reports Source Type: news

Catheter-based intervention drains endometrial cysts
South Korean researchers found that by replacing an interventional needle with...Read more on AuntMinnie.comRelated Reading: USPSTF again nixes screening for ovarian cancer Women with endometriosis have higher heart disease risk Ultrasound should be 1st choice for female pelvic imaging The Practice of Ultrasound: Part 4 -- Female pelvic ultrasound Rigorous investigation using MRI can prove crucial for endometriosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 31, 2018 Category: Radiology Source Type: news

Postmenopausal Bleeding Common in Women With Endometrial Cancer
A meta-analysis finds that postmenopausal bleeding occurs in approximately 90% of women with endometrial cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 30, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Oral Contraceptive Use and Risks of Cancer Oral Contraceptive Use and Risks of Cancer
While oral contraceptive use has been well studied in terms of breast, ovarian, and endometrial cancers, this analysis investigated the total effect of OC use on cancer risk across all organs.American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Sentinel Lymph Node Mapping Most Cost - Effective for Uterine CA
Findings compared to routine, selective lymphadenectomy for low - risk endometrial cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 21, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news

Sentinel Lymph Node Mapping Most Cost-Effective for Uterine CA
TUESDAY, Aug. 21, 2018 -- Sentinel lymph node mapping has the lowest costs and highest quality-adjusted survival compared to both routine and selective lymphadenectomy for managing low-risk endometrial carcinoma, according to a study published in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2018 Category: Pharmaceuticals Source Type: news

Most Postmenopausal Bleeding Not Associated With Cancer
TUESDAY, Aug. 14, 2018 -- Most women with postmenopausal bleeding (PMB) will not be diagnosed with endometrial cancer, according to a review published online Aug. 6 in JAMA Internal Medicine. Megan A. Clarke, Ph.D., from the National Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2018 Category: Pharmaceuticals Source Type: news

Postmenopausal Bleeding and Endometrial Cancer
Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 9, 2018 Category: General Medicine Source Type: news

Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer Postmenopausal Bleeding: Reliable Sign of Endometrial Cancer
Almost all women with endometrial cancer have postmenopausal bleeding (PMB), although only a small proportion of women with PMB will be diagnosed with endometrial cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Postmenopausal Bleeding Should Prompt Endometrial Ca Evaluation
(MedPage Today) -- But patient counseling needed, as only 10% of such cases are cancer (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 7, 2018 Category: Hematology Source Type: news

How common is endometrial cancer in women with postmenopausal bleeding?
(JAMA Network) Postmenopausal bleeding is a common symptom among most women with endometrial cancer but most women with   postmenopausal bleeding won't be diagnosed with endometrial cancer, findings that raise questions about how to best manage postmenopausal bleeding for the early detection of endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Women's Wellness: Endometrial cancer -- risk factors, screening, treatment
DEAR MAYO CLINIC:?My sister, who is 56, recently was diagnosed with early-stage endometrial cancer. I?m wondering if this kind of cancer runs in families. Could I be at risk for it, too? Are there other things that can raise a woman?s risk for endometrial cancer? Are there any screening tests available for it? ANSWER:?An increased [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 26, 2018 Category: Databases & Libraries Source Type: news

Extended Tamoxifen May Double Endometrial Cancer Risk
(MedPage Today) -- But observed malignancies were detected early and carried low mortality risk (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 10, 2018 Category: Hematology Source Type: news

Top oncologist to study effect of diet on cancer drugs
Siddhartha Mukherjee says trial is first in a series on ‘rethinking human diets for cancer’A groundbreaking clinical trial on whether diet could boost the effectiveness of cancer drugs is set to be launched by one of the world ’s leading oncologists.The work, led bySiddhartha Mukherjee atColumbia University Medical Center in New York, will investigate whether a high-fat, low-carbohydrate diet could improve outcomes for patients with lymphoma and endometrial cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 6, 2018 Category: Science Authors: Hannah Devlin Science correspondent Tags: Cancer research Medical research Siddhartha Mukherjee Science Diets and dieting Health Source Type: news

Breast-cancer drug taken by thousands of women doubles the risk of womb cancer
Researchers from St Vincent's Hospital Group, Dublin, found that taking tamoxifen for 10 years rather than five raises the risk of endometrial cancer from 1.5 per cent to 3.5 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

Extended tamoxifen therapy may increase risk of endometrial cancer
(Wiley) There is clear evidence that extended adjuvant tamoxifen therapy for 10 years reduces local recurrence and improves breast cancer-free survival in women with oestrogen receptor-positive breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2018 Category: Cancer & Oncology Source Type: news

Olaparib Plus Vistusertib Promising in Early Trial of Endometrial, Other Cancers
Dave LevitanJun 6, 2018The combination of the PARP inhibitor olaparib with the mTORC1/2 inhibitor vistusertib had promising activity across endometrial, ovarian, and triple-negative breast cancers. (Source: CancerNetwork)
Source: CancerNetwork - June 6, 2018 Category: Cancer & Oncology Authors: A Source Type: news

Gene sequencing study finds new cancers linked with Lynch syndrome
CHICAGO (Reuters) - Lynch syndrome, a rare hereditary disease typically associated with an increased risk of colorectal and endometrial cancers, appears to be linked with several additional types of cancer than previously thought, U.S. researchers said on Saturday. (Source: Reuters: Health)
Source: Reuters: Health - June 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

CVD Risk Elevated in Endometrial Ca Survivors (CME/CE)
(MedPage Today) -- Call for careful monitoring, risk management for up to 10 years after cancer diagnosis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 13, 2018 Category: Cardiology Source Type: news

Long-Term Cardiovascular Risk for Endometrial Cancer Survivors
TUESDAY, May 8, 2018 -- Endometrial cancer survivors have an elevated risk of various adverse long-term cardiovascular outcomes, according to a study published online May 8 in the Journal of the National Cancer Institute. Sean Soisson, from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Endometrial cancer telephone follow-up, a good call
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2018 Category: Drugs & Pharmacology Source Type: news

Can Diabetes Lead to Irregular Periods in Teens?
In the long-term, irregular periods can also increase the risk of endometrial cancer, the researchers pointed out in the new report. (Source: WebMD Health)
Source: WebMD Health - April 25, 2018 Category: Consumer Health News Source Type: news

Hologic wins FDA PMA for ThinPrep automated Pap test imager
Hologic (NSDQ:HOLX) said today it won FDA premarket approval for its ThinPrep integrated imager designed for the automated imaging of Pap tests. The Marlborough, Mass.-based company’s ThinPrep imager is designed to aid cytology technicians in identifying abnormal cells, and combines an imaging station and review scope into a single unit. The system takes approximately 90 seconds to analyze samples, the company said. “Approval of the ThinPrep Integrated Imager brings the benefits of ThinPrep automated Pap imaging to small- and mid-sized laboratories in the United States, and of course to their patients...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Women's Health Hologic Source Type: news

Duo win prestigious pathology award for endometrial cancer study
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - April 12, 2018 Category: Cancer & Oncology Source Type: news

Studies Seek Role for Anti-PD-1 Drugs in Gyn Cancers
(MedPage Today) -- Activity in resistant ovarian, mutated endometrial cancers (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2018 Category: Hematology Source Type: news

Could ER/GR Interplay Affect Endometrial Cancer Prognosis?
Researchers discovered that estrogen receptor alpha and glucocorticoid receptor are simultaneously expressed in many endometrial cancers, and may be associated with poor prognosis. (Source: CancerNetwork)
Source: CancerNetwork - March 28, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Endometrial Cancer News Source Type: news

Everolimus Plus Letrozole Effective in Endometrial Carcinoma
Findings from the GOG-3007 study suggest everolimus plus letrozole might be effective in advanced persistent or recurrent endometrial carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - March 27, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Endometrial Cancer News Conferences/SGO Source Type: news

The connection between diet, obesity, and cancer: Nutrition experts explore the evidence
(Elsevier) About one third of cancer cases are estimated to be linked to dietary and other modifiable risk factors, especially for obesity-related cancers such as breast, colorectal, ovarian, endometrial, kidney, gallbladder, esophageal, and pancreatic cancers. In this special theme issue of the Journal of the Academy of Nutrition and Dietetics, food and nutrition practitioners and other health professionals take an in-depth look at the relationship between nutrition, obesity, and cancer prevention, treatment, and survival and identify research gaps for future prevention research efforts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2018 Category: International Medicine & Public Health Source Type: news

Updating smear tests could save thousands of women's lives
Researchers from  Johns Hopkins University found assessing cervical fluid collected in smears for DNA mutations accurately detects 81 per cent of endometrial and 33 per cent of ovarian cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 22, 2018 Category: Consumer Health News Source Type: news

Modified Pap tests can show early warning signs of other gynecological cancers
The Pap test has already reduced the incidence of cervical cancerby more than 60%. Now it may become a key step in the early detection of two other gynecological malignancies — ovarian and endometrial cancers — that have been notorious killers because they’re typically caught so late.A new study... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - March 22, 2018 Category: Science Authors: Melissa Healy Source Type: news

Pap test fluids used in gene-based screening test for two gyn cancers
(Johns Hopkins Medicine) Cervical fluid samples gathered during routine Papanicolaou (Pap) tests are the basis of a new screening test for endometrial and ovarian cancers developed by researchers at the Johns Hopkins Kimmel Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2018 Category: Cancer & Oncology Source Type: news

Could a Pap Test Spot More Than Cervical Cancer?
The researchers behind the new study developed a testing regimen called PapSEEK to see if additional samples collected during a pelvic exam could be used to detect endometrial or ovarian cancer. (Source: WebMD Health)
Source: WebMD Health - March 21, 2018 Category: Consumer Health News Source Type: news

PapSEEK: Potential Screening Test for Gynecologic Cancers PapSEEK: Potential Screening Test for Gynecologic Cancers
A multiplex panel that detects mutations in endometrial and ovarian cancers using samples from a routine Pap test and that also provides an analysis of aneuploidy may emerge as a screening tool.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Surprising discovery provides insights into aggressive endometrial cancers
(Huntsman Cancer Institute) New research from Huntsman Cancer Institute (HCI) at the University of Utah (U of U) indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 13, 2018 Category: Cancer & Oncology Source Type: news

Switching on survival signalling to drive drug resistance
(Queen Mary University of London) Researchers at Queen Mary University of London have discovered that the loss of a single protein- PHLDA1- is sufficient for the development of drug resistance to a type of targeted therapy in endometrial and HER2-positive breast cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 27, 2018 Category: Cancer & Oncology Source Type: news

Adjuvant Chemo in Endometrial Cancer: Benefit Only for Some Adjuvant Chemo in Endometrial Cancer: Benefit Only for Some
PORTEC-3 results show that adjuvant chemotherapy improves failure-free survival, although not overall survival, in women with stage III high-risk endometrial cancer, but not in less advanced disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lower Risk of Some Cancers With Oral Contraceptives Applies Across Lifestyles Lower Risk of Some Cancers With Oral Contraceptives Applies Across Lifestyles
Women who use oral contraceptives for at least a decade may be less likely to develop ovarian or endometrial malignancies, and this benefit doesn ’ t seem to be diminished by other lifestyle risk factors, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lower risk of certain cancers with the Pill applies across lifestyles
(Reuters Health) - Women who use oral contraceptives for at least a decade may be less likely to develop ovarian or endometrial malignancies, and this benefit doesn ’t seem to be diminished by other lifestyle risk factors, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Vaginal Estrogen for GSM and Risk of Endometrial Cancer Vaginal Estrogen for GSM and Risk of Endometrial Cancer
Concerns remain regarding the safety of low-dose vaginal estrogen for the treatment of genitourinary syndrome of menopause. What does the latest evidence show?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 26, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Oral Contraceptives Reduce Risk for Ovarian and Endometrial Cancers
The effect is especially evident in smokers, the obese and those who exercise infrequently. (Source: NYT Health)
Source: NYT Health - January 19, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Smoking and Tobacco Birth Control and Family Planning Cancer Ovaries Source Type: news